Definium Therapeutics, Inc. Strategic Asset Allocation Index
Definium Therapeutics, Inc. strategic asset allocation index. Definium Therapeutics, Inc. (DFTX) has a Strategic Asset Allocation Index of 29.6% as of June 2025. Strategic assets (PP&E of $- plus long-term investments of $54.86 Million) total $54.86 Million, measured against net assets of $185.40 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Definium Therapeutics, Inc. balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Definium Therapeutics, Inc. Strategic Asset Allocation Index by Year (None–None)
Definium Therapeutics, Inc. strategic asset allocation index by year from None to None. The table below presents the year-by-year Strategic Asset Allocation Index for Definium Therapeutics, Inc. from None to None, covering 0 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Definium Therapeutics, Inc. market cap and net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|